在异胎妊娠的管理中使用甲托雷克萨特:一项回顾性研究
Megan E Slattery1, Henry J Nava2, Hayley M Spoljaric3
1Obstetrics and Gynecology, Ross University School of Medicine, Chicago, USA.
Cureus
|December 2, 2025
概括
较低的基线β-人类胆管性淋巴激素 (β-hCG) 水平预测子宫外怀孕中甲状腺素的成功. 较高的β-hCG水平显著增加了手术干预的需要和甲状腺素失败.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 妇科 妇科医生 妇科
- 药理学 药理学是指药理学的学科.
背景情况:
- 宫外怀孕 (EP) 存在重大风险,包括破裂和危及生命的并发症.
- 甲基 (MTX) 是稳定PE的常见治疗方法,但其成功率各不相同.
- 管内EP中MTX疗效的预测因素尚不清楚.
研究的目的:
- 评估MTX在治疗输卵管EP方面的疗效.
- 确定MTX治疗成功和失败的临床预测因素.
- 探索对EP的医疗管理的现实世界的障碍.
主要方法:
- 对37名患有输卵管EP的女性进行了回顾性队列研究.
- 分析初始β-hCG水平,超声检查结果和MTX剂量.
- 结果的比较,包括解决时间和需要手术的情况.
主要成果:
- 在24%的患者中观察到MTX的成功,主要是β-hCG水平在1578-4340 mIU/mL之间.
- 当β-hCG超过4340 mIU/mL时,没有MTX成功.
- 升高的基线β-hCG显著预测了手术干预 (p=0.043) 和MTX失败.
结论:
- 较低的基线β-hCG水平是MTX治疗成功的最强预测因素.
- 升高的β-hCG与MTX衰竭和增加外科手术的需要有关.
- 系统支持门诊管理和患者选择医疗治疗需要优化.
更多相关视频
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
10.0K
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
3.7K
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461
